However, the first studies did not show an association between SLC26A6 variants and hyperoxaluria/hyperoxalemia or the risk of nephrolithiasis in these cohorts (Monico et al., 2008; Corbetta et al., 2009; Scherer et al., 2023). This evidence concerns the gene SLC26A6 and nephrolithiasis.